Evidence map›Paper›PMID 31933982›Full record

ArticleInternational journal of clinical and experimental pathology2019

Chondroid gastrointestinal stromal tumor in the stomach with early adenocarcinoma.

Guohua Yu, Ping Yang, Wenwen Ran, Xiaoming Xing, Ting Wang, Shishou Wu, Xubo Pan, Guimei Qu, Pengzhou Gai, Weifang Ding

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Guohua YuDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Ping YangDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Wenwen RanDepartment of Pathology, Affiliated Hospital, Qingdao University Qingdao, China.
Xiaoming XingDepartment of Pathology, Affiliated Hospital, Qingdao University Qingdao, China.
Ting WangDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Shishou WuDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Xubo PanDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Guimei QuDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Pengzhou GaiDepartment of Surgery, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Weifang DingDepartment of Internal Medicine, Affiliated Yantai Yuhuangding Hospital, Qingdao University Yantai, China.
Yuhuangding Hospital · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the pathologic features of gastric chondroid gastrointestinal stromal tumors.

methodsThe clinicopathologic data of one case of gastric chondroid gastrointestinal stromal tumor were collected and the features were analyzed by literature review.

resultsThe male patient was 64 years old and had suffered from upper abdominal fullness discomfort without obvious cause for 5 years. Gastroscopic examination showed a rough area located in the lesser curvature of the gastric antrum, measuring 6 cm × 4 cm. CT scan showed the stomach wall was unevenly thick at the gastric antrum and stomach outlet. Multiple enlarged lymph nodes were seen nearby. The biopsy pathology showed adenocarcinoma of gastric antrum. The patient underwent laparoscopic gastrectomy and gastric chondroid gastrointestinal stromal tumor was found with adenocarcinoma of the stomach. Asp842Val mutation was found in the PDGFRα 18 exon.

conclusionGastric chondroid gastrointestinal stromal tumors are rare and low risk. Tumor cells express CD117 and Asp842Val mutation in the PDGFRα 18 exon revealed by genetic sequencing suggesting this kind of tumor might be resistant to imatinib.

Indexed as

chondroidearly adenocarcinomaGastrointestinal stromal tumor

Identifiers

PMID31933982
PMCPMC6947111
OpenAlexW3005047370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.